Vasopressin role in hypertrophic obstructive cardiomyopathy post-cardiac surgery: A case report
Vasopressin seems to be the preferred vasopressor for managing LVOTO and SAM post-cardiac surgery, because of its absence of inotropic effects. Echocardiography is crucial for early diagnosis and therapeutic management.
Authors
- George Ν. Konstantinou (ORCID: https://orcid.org/0000-0003-1371-6764)
- Eleni Tzatzaki (ORCID: https://orcid.org/0000-0002-6370-4713)
- Fotios Dimitriadis (ORCID: https://orcid.org/0000-0003-1198-9144)
- Nektarios Kogerakis (ORCID: https://orcid.org/0000-0002-6762-6054)
- Stavros Dimopoulos (ORCID: https://orcid.org/0000-0003-2199-3788)
- Konstantina Kolonia (ORCID: https://orcid.org/0000-0003-0872-0056)
- Dimitrios Elaiopoulos
- Michalis Antonopoulos
- Maria Chronaki
Institutions
- Onassis Cardiac Surgery Center (GR)
Publication Details
- Journal
- World Journal of Critical Care Medicine
- Published
- 2025-11-28
- DOI
- https://doi.org/10.5492/wjccm.v14.i4.106485
- Primary Topic
- Cardiomyopathy and Myosin Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00